Brudnick Richard
SEC-identified person · CIK 1692359 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Scholar Rock Holding Corp SRRK | Director | filed 2023 - 2026 |
| Inflarx N.V. IFRX | Director | filed 2026 - 2026 |
| Prime Medicine, Inc. PRME | Chief Business Officer | filed 2022 - 2025 |
| Volitionrx LTD VRNX | Director | filed 2021 - 2023 |
| Codiak Biosciences, Inc. CDAK | See Remarks | filed 2020 - 2022 |
| Bioverativ Inc. BIVV | EVP, Business Development | filed 2016 - 2018 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.